Loading, Please Wait...
CARLSBAD, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor conferences.
GenMark’s management team will be participating in one-on-one meetings at the BTIG MedTech, Life Science & Diagnostic Tools Conference in Snowbird, Utah on Thursday, February 28, 2019. Due to the format of this event no webcast will be available.
GenMark’s management is also scheduled to present at the Cowen Annual Health Care Conference in Boston, Massachusetts on Wednesday, March 13th, 2019 at 10:00 a.m. ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com.
About GenMark Diagnostics
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor® detection technology, GenMark's eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.
Investor Relations Contact
Lynn Pieper Lewis or Leigh Salvo